Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.
about
The Role of PPARs in CancerMetformin as a new anti-cancer drug in adrenocortical carcinomaProteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interactionCancer biology in diabetes.Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.Emerging therapy for adrenocortical carcinoma.Current and emerging therapies for advanced adrenocortical carcinoma.The insulin and igf-I pathway in endocrine glands carcinogenesisCurrent and emerging therapeutic options in adrenocortical cancer treatment.The potential of antidiabetic thiazolidinediones for anticancer therapy.Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells.Adrenocortical tumorigenesis.Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARgamma Dependent and Independent MechanismsAdrenocortical dysregulation as a major player in insulin resistance and onset of obesity.Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeysmRNA and microRNA expression patterns in adrenocortical cancer.Adrenocortical growth and cancer.Adrenocortical tumors and insulin resistance: What is the first step?Antitumoral effects of 9-cis retinoic acid in adrenocortical cancer.Rosiglitazone inhibits alpha4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor gamma-independent signals.Rosiglitazone inhibits adrenocortical cancer cell proliferation by interfering with the IGF-IR intracellular signaling.Rosiglitazone, an Agonist of PPARgamma, Inhibits Non-Small Cell Carcinoma Cell Proliferation In Part through Activation of Tumor Sclerosis Complex-2.Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway.
P2860
Q21342955-79B2FE44-C57A-4171-992C-E3E957837262Q28468634-0BE6B86A-7EFD-4D88-AD65-AF59F675B161Q28484038-D239AEF3-7161-44B8-ABDC-051E079A8294Q33608038-4D492A29-7957-4CAF-80B9-63AF2B71F4E8Q34099115-159A6501-0E56-4975-AF07-DAE1FAAFD121Q35018399-14D8BFE7-840B-4E7F-8FCA-A87F2E234032Q35584305-A3BEB783-FC91-45D9-AC19-938956C6A55DQ36178421-322843C8-410A-4796-8399-64B57CB339A6Q36183873-B73115D2-292D-43BC-885B-E86D5026E782Q36568732-D3A13E71-03CE-4E59-A72D-4EA6A5F66907Q36611745-21A78BEA-FB42-447D-8886-067463FB521FQ36694025-59616057-9702-4E03-98FE-77AD70EDE3CEQ36890814-3AD854C3-7456-42F2-B53D-301CF766B531Q36958256-270D8249-859E-453C-B973-EED727D85FDEQ37250408-326E020F-C302-483B-A517-9DBA7846CFF1Q37945250-88300600-3224-4406-98FC-BA3DCA43216CQ38318638-E733F81B-E043-404B-91BE-4907AC74BCBAQ38659703-A990A5A2-325A-4821-9B42-929D6784D109Q39134041-05CDE89F-AF2C-4D7D-9686-BDA4211F4048Q39896243-D2C8F5FF-41FE-463F-9C90-D4CC2A6208EAQ39955398-41AA0F50-E6CB-4842-B6B7-4FA146B971CCQ42745788-2FCA14F9-6C3A-4947-87AC-4CDDB0B8681CQ53412983-5E7805E5-0A04-49C7-80C2-03B1EDA696A5
P2860
Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Thiazolidinediones inhibit gro ...... rtical cancer cell line H295R.
@en
type
label
Thiazolidinediones inhibit gro ...... rtical cancer cell line H295R.
@en
prefLabel
Thiazolidinediones inhibit gro ...... rtical cancer cell line H295R.
@en
P2093
P50
P356
P1476
Thiazolidinediones inhibit gro ...... rtical cancer cell line H295R.
@en
P2093
Cecilia Grappone
Gianna Fiorelli
Mario Serio
Pietro Ferruzzi
P304
P356
10.1210/JC.2004-0978
P407
P577
2004-12-07T00:00:00Z